Hepatitis C Drug Market To Reach USD 26.9 Billion By 2032 Report By DataHorizzon Research Fort Collins, Colorado, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The Hepatitis C Drug Market was valued at USD 20.8 Billion in 2022 and is anticipated to reach USD 26.9 Billion by 2032 at a CAGR of 2.7%. ...

Hepatitis C Drug Market Size & Share to Surpass $56.5 Billion by 2030 | Vantage Market Research    WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Hepatitis C Drug Market is estimated to be valued at USD 56.5 Billion by 2030 and is expected to...

Hepatitis C Drugs Market to Reach US$ 7,351.7 Mn by 2026, Increasing Regulatory Approvals Will Help Market Regain Momentum, says Fortune Business Insights Pune, Oct. 17, 2019 (GLOBE NEWSWIRE) -- The global Hepatitis C Drugs Market will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by...

Global Hepatitis C Drug Market Poised to Surge from USD 11.81 Billion in 2015 to USD 27.63 Billion by 2021 – MarketResearchStore.Com Deerfield Beach, FL, July 20, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs...